Aquestive Therapeutics, Inc. cotiza a 4.67 USD y tiene una capitalización bursátil de $586M. En los últimos 12 meses ha facturado $54M con un margen de flujo de caja libre del -119.0%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; EMYL…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | — | $-0.05 | $-0.14 |
| Estimado | $-0.12 | $-0.12 | $-0.13 | $-0.12 |
| Sorpresa | — | — | +61.5% | -16.7% |
| Métrica | AQST | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 58.4% | 57.0% | +1.3% |
| Operating Margin | -159.5% | -38.6% | -120.9% |
| Net Margin | -188.1% | -33.6% | -154.5% |
| FCF Margin | -119.0% | -13.9% | -105.1% |
| ROE | — | -40.4% | — |
| ROA | -52.2% | -32.0% | -20.2% |
| Current Ratio | 3.14 | 2.84 | +0.30 |
| Debt / Equity | -1.34 | 0.28 | -1.62 |